IATI Biomed 2016 Conference Program has nine main tracks consisting of invited Lectures/Panels and company presentations.
Trending topics have been identified and through this focused track approach, participants have the opportunity to gain a deeper understanding and more insight into the subjects.
IATI Biomed 2016 Conference tracks are:
- The Promise of Immuno-oncology
- Neurological Disorders
- Personalized Diagnostics and Precision Medicine
- Listen to your Aching Heart
- Health IT
- Early Stage Challenges and Opportunities
- Robotics’ Role in Healthcare
- The New “Kids” on the block
* Microbiome
* Gene Editing and Gene Therapy - From Academia Research to Industry
PRELIMINARY. ALL TIME SLOTS WITHIN TRACKS ARE SUBJECT TO CHANGE.
| TUESDAY, MAY 24, 2016 | |
| 07:30-17:00 | Registration Open |
| 09:00 - 09:20 | Welcome and Opening Remarks: Ruti Alon, General Partner, Pitango Venture Capital, IATI Biomed Co-Chairperson Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners, IATI Biomed Co-Chairperson Yaky Yanay, President, Pluristem and IATI Co-Chairperson |
| 09:20-10:00 | Opening Keynote Lecture: Patrick Terry, President, GMPO Orphan and Sharon Terry, President and CEO of Genetic Alliance interviewed by Dana Weiss, Anchor and Senior Correspondent, Israel's Channel 2 News |
| 10:00-10:40 | Keynote Lecture: Francois Maisonrouge, Senior Managing Director, Evercore Partners - "The recent market correction in Health Care: a reflection of changing fundamentals?" |
| 10:40-11:10 | Coffee Break |
| 11:10-17:30: | The Promise of Immuno-Oncology Hall A |
| 11:10-11:55: | Chairperson: Prof. Gal Markel, MD, PhD, Sheba Medical Center - "Immuno-oncology innovations from a research medical center" |
| 11:55-12:40: | Dr. Arie Belldegrun, MD, Chairman, President & Chief Executive Officer, Kite Pharma - "Engineered T cell Immunotherapy: The future is here" |
| 12:40-13:30: | Loic Vincent, Head, Oncology External Innovation,Strategy, Science Policy & External Innovation, Sanofi - “Out of The Box Immuno-Oncology” |
| 13:30-14:30: | Lunch Break |
| 14:30-14:45: | Compugen Ltd. |
| 14:45-15:00: | BioLineRx Ltd. |
| 15:00-15:15: | Vascular BioGenics Ltd. |
| 15:15-15:30: | Silenseed Ltd. |
| 15:30-15:45: | Kahr Medical Ltd. |
| 15:45-16:00: | Efranat Ltd. |
| 16:00-16:15: | Immune Oncology Pharmaceuticals |
| 16:15-17:30: | Panel Moderator: Dr. Luisa Salter-Cid, Vice-President, Immunoscience, Bristol-Myers Squibb Panelists: Prof. Gal Markel MD, PhD, Sheba Medical Center Dr. Anat Cohen-Dayag, President and CEO of Compugen Prof. Yoram Reiter, Head of Molecular Immunology Lab, Technion Aya Jakobovits, CEO , Adicet Bio |
| Moderator: | |
| Dr. Luisa Salter-Cid, Vice-President, Immunoscience, Bristol-Myers Squibb | |
| Panelists: | |
| Jason Coloma, Vice President and Global Therapeutic Area Head of Oncology in Roche Partnering, Roche Pharma | |
| 17:30-19:00: | Gala Event |
| TUESDAY, MAY 24, 2016 | |
| 07:30-17:00: | Registration Open |
| 09:00 - 09:20 | Welcome and Opening Remarks: Ruti Alon, General Partner, Pitango Venture Capital, IATI Biomed Co-Chairperson Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners, IATI Biomed Co-Chairperson Yaky Yanay, President, Pluristem and IATI Co-Chairperson |
| Ruti Alon, General Partner, Pitango Venture Capital, IATI Biomed Co-Chairperson | |
| Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners, IATI Biomed Co-Chairperson | |
| Yaky Yanay, President, Pluristem and IATI Co-Chairperson | |
| 09:20-10:00: | Opening Keynote Lecture: Patrick Terry, President, GMPO Orphan and Sharon Terry, President and CEO of Genetic Alliance interviewed by Dana Weiss, Anchor and Senior Correspondent, Israel's Channel 2 News |
| Patrick Terry, President, GMPO Orphan and Sharon Terry, President and CEO of Genetic Alliance | |
| Interviewer: Francois Maisonrouge, Senior Managing Director, Evercore Partners | |
| 10:00-10:40: | Keynote Lecture: Francois Maisonrouge, Senior Managing Director, Evercore Partners - ''The recent market correction in Health Care: a reflection of changing fundamentals?'' |
| Francois Maisonrouge, Senior Managing Director, Evercore Partners - ''The recent market correction in Health Care: a reflection of changing fundamentals?'' | |
| 10:40-11:10 | Coffee Break |
| 11:10-17:30: | Neurological Disorders Hall B |
| 11:10-11:20: | Jay D Kranzler, VP and Global Head, External R&D Innovation – Biotherapeutics and Strategic Investments, Pfizer, Inc. - ''CNS Therapeutics: From Starting Point to Tipping Point'' |
| 11:20-12:00: | Henry O Gosebruch, Executive Vice President and Chief Strategy officer, Abbvie - ''The Starting Point: The CNS Ecosystem as it Stands Today'' |
| 12:00-12:40: | Tetsuyuki Maruyama, Chief Scientific Officer, Dementia Discovery Fund - ''New Financing Vehicles: The Dementia Discovery Fund Example'' |
| 12:40-13:20: | Prof. Michal Schwartz, the Maurice and Ilse Katz Professorial Chair in Neuroimmunology, Weitzmann Insititute - ''New Scientific Paradigms: Inflammation in Neurodegenerative Disease - Friend or Foe?'' |
| 13:30-14:30: | Lunch Break |
| 14:30-15:15: | Daniel R. Karlin, MD, MA, Senior Director, Pfizer Inc. |
| 15:15-15:30: | Miri Polachek, Executive Director at Israel Brain Technologies - ''Status of Israeli Braintech – Current and Future'' |
| 15:30-16:00: | Amir Amedi, Associate Professor of Medical Neurobiology and Cognitive Sciences, Hebrew University of Jerusalem - ''Academic Research – New frontiers in rehab medicine by combining sensory substation with bionic prostheses'' |
| 16:00-16:30: | Established Company Panel Panelists: Ronen Gadot, Chief Executive Officer, Elminda Guy Ezekiel , CEO, Brainsway Yaron Danieli, CEO, Alcobra |
| 16:30-16:45: | ALS Analyzer |
| 16:45-17:00: | NIBS Neuroscience |
| 17:00-17:15: | Neurosteer |
| 17:15-17:30: | Medymatch |
| 17:30-19:00 | Gala Event |
| TUESDAY, MAY 24, 2016 | |
| 07:30-17:00 | Registration Open |
| 09:00 - 09:20: | Welcome and Opening Remarks: Ruti Alon, General Partner, Pitango Venture Capital, IATI Biomed Co-Chairperson Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners, IATI Biomed Co-Chairperson Yaky Yanay, President, Pluristem and IATI Co-Chairperson |
| Ruti Alon, General Partner, Pitango Venture Capital, IATI Biomed Co-Chairperson | |
| Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners, IATI Biomed Co-Chairperson | |
| Yaky Yanay, President, Pluristem and IATI Co-Chairperson | |
| 09:20-10:00: | Opening Keynote Lecture: Patrick Terry, President, GMPO Orphan and Sharon Terry, President and CEO of Genetic Alliance interviewed by Dana Weiss, Anchor and Senior Correspondent, Israel's Channel 2 News |
| Patrick Terry, President, GMPO Orphan and Sharon Terry, President and CEO of Genetic Alliance | |
| Interviewer: Francois Maisonrouge, Senior Managing Director, Evercore Partners | |
| 10:00-10:40: | Keynote Lecture: Francois Maisonrouge, Senior Managing Director, Evercore Partners - ''The recent market correction in Health Care: a reflection of changing fundamentals? |
| Francois Maisonrouge, Senior Managing Director, Evercore Partners - ''The recent market correction in Health Care: a reflection of changing fundamentals? | |
| 10:40-11:10 | Coffee Break |
| 11:10-17:30: | Early Stage Challenges and Opportunities Hall C |
| 11:10 - 11:20: | Chairperson: Assaf Barnea, CEO, Sanara Ventures |
| 11:20 - 12:00: | Jeroen Tas, CEO, Connected Care & Health Informatics, Philips |
| 12:00-12:30: | Dr. Wei Siang Yu, Healthcare Futurist, Founder and Executive Chairman of Borderless Healthcare Group |
| 12:30-13:30: | Round Table Discussions: 1. Alternative Financing Models: Jon Medved, Founder and CEO, OurCrowd James Rogers III, J.D. The chair of Mayo Clinic Ventures David Revcolevschi, Partner, Paul Hastings Anya Eldan, GM of Early Stage Companies and Incubators, Israel Innovation Authority Dana Chanan,CEO , Sweetch Galit Zuckerman, CEO, Medasense Evan Norton , Divisional Vice President, Venture Investments at Abbott Ventures Nissim Darvish, MD, PhD, Senior Managing Director, OrbiMed |
| 1. Alternative Funding Models: | |
| Jon Medved, Founder and CEO, OurCrowd | |
| James Rogers III, J.D. The chair of Mayo Clinic Ventures | |
| David Revcolevschi, Partner, Paul Hastings | |
| Albert Ganyushin, Head of International Listings at Euronext | |
| Anya Eldan, GM of Early Stage Companies and Incubators, Israel Innovation Authority | |
| Dana Chanan,CEO , Sweetch | |
| 13:30-14:30 | Lunch Break |
| 14:30-15:20: | 2. Introducing Innovation into Developing Countries: Dr. Yehoshua (Shuki) Gleitman, Chairman of GIBF (Global Independent Baptist Fellowship) Avinoam Sapir, CEO, Teva Israel & Head of Innovation Growth Markets Eddy Horowitz, CEO, Circ MedTech Ariel Ikan, CEO, Philips Health Care, Israel Seth Salpeter, Chief Science Officer & VP Business Development, Sight Diagnostic Dr. Wei Siang Yu, Healthcare Futurist, Founder and Executive Chairman of Borderless Healthcare Group Nadav Kidron, CEO, Oramed Prof. Pinny Halperin, Associate Professor of Emergency Medicine, Chair of Emergency, Tel Aviv Medical Center |
| 15:20-16:10: | Round Table Discussions: 3. From Sickcare to Healthcare: David Groberman, CEO, Co-Founder, HeraMED Assaf Sella, CEO, Kytera Technologies Yoram Feldman, Director of ReAbility Tele-Rehab Technologies at Gertner Institute Dr. Yair Birnbaum, Chief Medical Officer of Clalit Healthcare Services Gil Adato, VP, Head of Business Development & Connected Value Propositions Connected Digital Platforms & Propositions (CDP2), Royal Philips Elad Bassan, Operations Manager, Teva Amir Kesten, Director, Teva |
| 3. From Sickcare to Healthcare: | |
| Michael Tal, Founder of Lacrima Medical | |
| Asaf Sella, CEO, Kytera | |
| Technologies | |
| Sven Hermans, Head of Strategy & Business Development Philips Personal | |
| Yoram Feldman, Director of ReAbility Tele-Rehab Technologies at Gertner Institute | |
| Dr. Yair Birnbaum, Chief Medical Officer of Clalit Healthcare Services | |
| 16:10-17:00: | 4. Introducing Unique Points of Care: Mark Coticchia, Vice President and Chief Innovation Officer, Henry Ford Health System Dr. Scott Dulchavsky, CEO of The Henry Ford Innovation Institute and also serves as the Roy D. McClure Chairman of Surgery and the Surgeon in Chief at Henry Ford Hospital in Detroit Dr. Dalit Landesman, Chief Biologist, Biopmedical Efrat Marmur, Head of Innovation Technologies and Services ,Teva Israel Dr. Itamar Offer, Head of Israel's leading private hospital Hertzeliya Medical Center Avner Halperin, CEO, Earlysense John Milad, CEO, Quanta Fluid Solutions |
| 17:00-17:30 | Insights from Round Table Discussions: Mr Assaf Barnea, CEO, Sanara Ventures |
| 17:30-19:00: | Gala Event |